Jakub Hlávka, PhD, is a Research Assistant Professor in the Health Policy and Management Department of the Price School of Public Policy and Schaeffer Center for Health Policy & Economics, University of Southern California. His research interests include innovative payment for healthcare, health system reform, emerging therapies and the study of inequality.
Prof. Hlávka completed his PhD at the Pardee RAND Graduate School where he studied innovative payment approaches for emerging treatments like cell and gene therapies, specializing in cardiovascular conditions. At RAND, he also co-authored studies in national security, aerospace and emerging technologies and has served in research and consulting roles at the intersection of research finance, intellectual property, national security and governance at Genentech, the Fraunhofer Society, RAND Europe, Czech Government and the Czech Ministry of Finance. Dr. Hlávka holds degrees from Georgetown University and the University of Economics in Prague.
Prof. Hlávka teaches graduate-level health economics at the Sol Price School of Public Policy at USC.